DK0644746T3 - Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse - Google Patents
Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelseInfo
- Publication number
- DK0644746T3 DK0644746T3 DK93913793T DK93913793T DK0644746T3 DK 0644746 T3 DK0644746 T3 DK 0644746T3 DK 93913793 T DK93913793 T DK 93913793T DK 93913793 T DK93913793 T DK 93913793T DK 0644746 T3 DK0644746 T3 DK 0644746T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- moderate
- application
- delivery
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89726992A | 1992-06-11 | 1992-06-11 | |
PCT/US1993/004152 WO1993025168A1 (en) | 1992-06-11 | 1993-05-03 | The use of glycerin in moderating transdermal drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0644746T3 true DK0644746T3 (da) | 1999-12-20 |
Family
ID=25407656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93913793T DK0644746T3 (da) | 1992-06-11 | 1993-05-03 | Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0644746B1 (da) |
JP (1) | JPH08501529A (da) |
KR (1) | KR950701508A (da) |
AT (1) | ATE184473T1 (da) |
AU (1) | AU677206B2 (da) |
CA (1) | CA2135925C (da) |
DE (1) | DE69326461T2 (da) |
DK (1) | DK0644746T3 (da) |
ES (1) | ES2137993T3 (da) |
GR (1) | GR3031246T3 (da) |
HU (1) | HU221598B (da) |
NZ (1) | NZ253409A (da) |
WO (1) | WO1993025168A1 (da) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4429667C2 (de) * | 1994-08-20 | 1996-07-11 | Lohmann Therapie Syst Lts | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
US5601839A (en) * | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
DE19517145C2 (de) * | 1995-05-10 | 2000-02-24 | Hexal Pharmaforschung Gmbh | Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron |
US6572879B1 (en) * | 1995-06-07 | 2003-06-03 | Alza Corporation | Formulations for transdermal delivery of pergolide |
DE69630918T2 (de) * | 1995-06-09 | 2004-10-28 | Hisamitsu Pharmaceutical Co., Inc., Tosu | Matrix für Iontophorese |
US5908400A (en) * | 1996-06-20 | 1999-06-01 | Hisamitsu Pharmaceutical Co., Inc. | Device structure for iontophoresis |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
IT1294748B1 (it) | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
ES2318233T3 (es) * | 1997-11-10 | 2009-05-01 | Strakan International Limited | Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona. |
DE10019311A1 (de) * | 2000-04-19 | 2001-10-31 | Lohmann Therapie Syst Lts | Transdermale therapuetische Systeme zur Applikation von Moxonidin |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20030139384A1 (en) * | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
TR200300776T2 (tr) * | 2000-08-30 | 2005-10-21 | Unimed Pharmaceuticals, Inc. | Erkeklerde cinsel organ sertleşmemesinin tedavi edilmesi ve libidonun arttırılması için yöntem. |
EA009024B1 (ru) | 2002-06-25 | 2007-10-26 | АКРУКС ДиДиЭс ПиТиУай ЭлТиДи | Фармацевтическая композиция для чрескожной доставки активного агента (варианты) |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
JO2492B1 (en) * | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
US7879357B2 (en) * | 2003-04-28 | 2011-02-01 | Bayer Schering Pharma Ag | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
BRPI0611134A2 (pt) | 2005-06-03 | 2010-08-17 | Acrux Dds Pty Ltd | método e composição para liberação transdérmica de fármaco |
US8147815B2 (en) * | 2005-12-16 | 2012-04-03 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
MX2009007366A (es) | 2007-01-11 | 2009-07-16 | Acrux Dds Pty Ltd | Implemento para untar. |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
FR2924942B1 (fr) * | 2007-12-14 | 2012-06-15 | Pf Medicament | Compositions pharmaceutiques transcutanees contenant une hormone steroidienne |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
PL2952191T3 (pl) | 2009-06-12 | 2019-02-28 | Sunovion Pharmaceuticals Inc. | Apomorfina w postaci do podawania podjęzykowego |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2012083269A1 (en) | 2010-12-16 | 2012-06-21 | Cynapsus Therapeutics, Inc. | Sublingual films |
US20140037694A1 (en) * | 2011-02-25 | 2014-02-06 | Hisamitsu Pharmaceutical Co., Inc. | Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same |
JP6114401B2 (ja) | 2013-10-31 | 2017-04-12 | 久光製薬株式会社 | アジュバント組成物、これを含むアジュバント製剤、及びキット |
USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
US8785426B1 (en) | 2013-12-13 | 2014-07-22 | Upsher-Smith Laboratories, Inc. | Testosterone gel compositions and related methods |
CA3019769C (en) | 2015-04-21 | 2021-10-12 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
US9962444B2 (en) | 2016-09-27 | 2018-05-08 | Shane Malek | Pharmacokinetically extended action topical hair growth formulation, and administration method |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2920500A1 (de) * | 1979-05-21 | 1980-11-27 | Boehringer Sohn Ingelheim | Pharmazeutische zubereitung in form eines polyacrylatfilmes |
JPS6272611A (ja) * | 1985-09-27 | 1987-04-03 | Kao Corp | 皮膚外用剤 |
US5059189A (en) * | 1987-09-08 | 1991-10-22 | E. R. Squibb & Sons, Inc. | Method of preparing adhesive dressings containing a pharmaceutically active ingredient |
US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
GB9016056D0 (en) * | 1990-07-21 | 1990-09-05 | Chatfield Pharmaceuticals Limi | Transdermal medicine delivery devices |
DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
AU3070892A (en) * | 1991-11-12 | 1993-06-15 | Nepera, Inc. | Adhesive hydrogels having extended use lives and process for the preparation of same |
-
1993
- 1993-05-03 HU HU9403555A patent/HU221598B/hu not_active IP Right Cessation
- 1993-05-03 NZ NZ253409A patent/NZ253409A/en not_active IP Right Cessation
- 1993-05-03 ES ES93913793T patent/ES2137993T3/es not_active Expired - Lifetime
- 1993-05-03 DK DK93913793T patent/DK0644746T3/da active
- 1993-05-03 JP JP6501459A patent/JPH08501529A/ja active Pending
- 1993-05-03 AU AU43694/93A patent/AU677206B2/en not_active Expired
- 1993-05-03 AT AT93913793T patent/ATE184473T1/de active
- 1993-05-03 EP EP93913793A patent/EP0644746B1/en not_active Expired - Lifetime
- 1993-05-03 KR KR1019940704188A patent/KR950701508A/ko not_active Application Discontinuation
- 1993-05-03 CA CA002135925A patent/CA2135925C/en not_active Expired - Fee Related
- 1993-05-03 DE DE69326461T patent/DE69326461T2/de not_active Expired - Lifetime
- 1993-05-03 WO PCT/US1993/004152 patent/WO1993025168A1/en active IP Right Grant
-
1999
- 1999-09-16 GR GR990402338T patent/GR3031246T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU4369493A (en) | 1994-01-04 |
GR3031246T3 (en) | 1999-12-31 |
CA2135925C (en) | 2001-04-10 |
EP0644746B1 (en) | 1999-09-15 |
WO1993025168A1 (en) | 1993-12-23 |
NZ253409A (en) | 1996-09-25 |
EP0644746A1 (en) | 1995-03-29 |
HU221598B (hu) | 2002-11-28 |
JPH08501529A (ja) | 1996-02-20 |
AU677206B2 (en) | 1997-04-17 |
EP0644746A4 (en) | 1995-09-13 |
HUT71521A (en) | 1995-12-28 |
ATE184473T1 (de) | 1999-10-15 |
DE69326461D1 (de) | 1999-10-21 |
CA2135925A1 (en) | 1993-12-23 |
KR950701508A (ko) | 1995-04-28 |
ES2137993T3 (es) | 2000-01-01 |
HU9403555D0 (en) | 1995-02-28 |
DE69326461T2 (de) | 2000-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0644746T3 (da) | Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse | |
US5614211A (en) | Oxybutynin transdermal device having decreased delamination | |
US5238933A (en) | Skin permeation enhancer compositions | |
CA2517493C (en) | Therapeutic patch with polysiloxane matrix comprising capsaicin | |
US20050187212A1 (en) | Pharmaceutical composition for topical delivery of meloxicam | |
EP0922453A3 (en) | Percutaneous absorption type preparation containing tulobuterol | |
BR9713492A (pt) | ésteres de ácido graxo de ácido glicólico e seus sais como realçadores de permeação | |
DE3277453D1 (en) | Use of eucalyptol for enhancing skin permeation of bioaffecting agents | |
DK0971705T3 (da) | Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden | |
DE122012000021I1 (de) | Hautpenetrationsforderer sowie diese verwendende. | |
DK0957900T3 (da) | Sammensætninger og fremgangsmåder til topisk påföring af terapeutiske midler | |
WO1998037872A3 (en) | Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use | |
EP0251464A3 (en) | Composition for the control of insects | |
DK626484D0 (da) | Systemer til afgivelse af virksomme stoffer | |
LU86929A1 (de) | Neue topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung | |
NZ332746A (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease | |
ITMI990834A1 (it) | Cerotto per uso topico eparina e diclofenac | |
ES2074030A1 (es) | Composiciones portadoras, autocalentadoras y aplicables en terapeutica por via topica. | |
JPH03505835A (ja) | 経皮ドラッグデリバリーシステム | |
CA2096963C (en) | A two-phase topical composition | |
KR970705381A (ko) | 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템 | |
ES2188021T3 (es) | Metodo para evitar el uso indebido de un sistema terapeutico percutaneo. | |
US4834980A (en) | Transdermal delivery of azatidine | |
CA2548739A1 (en) | Uv-stable, liquid or semisolid transdermal administration form comprising a photosensitive active ingredient |